U.S. market Closed. Opens in 13 hours 28 minutes

TVTX | Travere Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312012-02-292011-02-282010-02-282009-02-28
Revenue145.24M212.02M227.49M198.32M175.34M164.25M154.94M133.59M99.89M28.20MN/AN/AN/AN/AN/AN/A
Cost of Revenue11.45M7.59M6.78M6.13M5.23M5.53M3.60M4.55M2.19M570.98KN/AN/AN/AN/AN/AN/A
Gross Profit133.79M204.43M220.71M192.19M170.10M158.72M151.33M129.04M97.71M27.63MN/AN/AN/AN/AN/AN/A
Operating Expenses521.93M455.99M360.21M267.57M269.91M227.41M182.13M168.87M129.97M107.44M23.97M30.26M12.82KN/AN/A13.43K
Selling, General & Admin265.54M220.21M149.88M135.80M128.95M103.65M103.96M98.02M79.54M59.64M16.89M30.26M12.82KN/AN/A13.43K
Research & Development244.99M235.78M210.33M131.77M140.96M123.76M78.17M70.85M50.43M47.80M7.08M662.50KN/AN/AN/AN/A
Other Operating Expenses11.39M974.00K231.00K1.42M-314.00K-474.00K1.11M-264.00K-296.00K570.98MN/A28.96BN/AN/AN/AN/A
Operating Income-376.74M-251.56M-139.50M-75.38M-99.81M-80.04M-53.79M-58.21M-50.75M-79.81M-23.97M-30.24M-12.82KN/AN/A-18.27K
Other Expenses / Income634.00K-11.34M19.74M-113.41M-46.64M-21.83M-30.19M-23.86M156.22M-33.89M-9.78M-86.84K-2.00KN/AN/AN/A
Before Tax Income-376.11M-278.17M-179.68M-188.79M-146.45M-101.87M-58.36M-57.58M105.47M-113.40M-33.75M-30.34M-14.82KN/AN/A-18.27K
Income Tax Expenses223.00K313.00K409.00K-19.36M-21.00K811.00K1.37M-9.68M-11.77M-2.46M75.78K2.75KN/AN/AN/AN/A
Net Income-111.40M-278.48M-180.09M-169.43M-146.43M-102.68M-59.73M-47.90M117.24M-110.94M-33.82M-30.34M-14.82KN/AN/A-18.27K
Interest Expenses11.33M11.28M20.14M19.05M18.83M9.81M1.19M34.48MN/AN/A19.50M105.92K2.00KN/AN/AN/A
Basic Shares Outstanding74.27M63.76M59.83M47.54M42.34M40.42M38.77M37.00M33.56M25.04M14.19M3.66M106.68KN/AN/A95.91M
Diluted Shares Outstanding74.27M63.76M59.83M47.54M42.34M40.43M38.77M38.29M37.58M25.06M14.21M3.66M106.68KN/AN/A95.91M
EBITDA-326.25M-299.42M-186.68M-143.95M-107.21M-73.39M-38.67M-38.79M129.46M-74.11M-34.29M-30.11M-12.82KN/AN/A-18.27K
EBITDA Margin-224.63%-141.22%-82.06%-72.59%-61.15%-44.68%-24.96%-29.03%129.60%-262.76%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-99.84M-266.89M-159.54M-169.74M-127.62M-92.06M-57.17M-23.10M105.47M-113.40M-14.24M-30.24M-12.82KN/AN/A-18.27K
EBIT Margin-68.74%-125.88%-70.13%-85.59%-72.79%-56.05%-36.90%-17.29%105.58%-402.07%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312012-02-292011-02-282010-02-282009-02-28
An error has occurred. This application may no longer respond until reloaded. Reload 🗙